U000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA

Audrey Belot, Ophélie Gourbeyre, Alexis Fay, Anais Palin, Celine Besson-Fournier, Chloé Latour, Corey R. Hopkins, George F. Tidmarsh, Hélène Coppin, Marie Paule Roth, Matthew R. Ritter, Charles C. Hong, Delphine Meynard

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalHaematologica
Volume105
Issue number3
DOIs
StatePublished - Mar 1 2020

ASJC Scopus subject areas

  • Hematology

Cite this

Belot, A., Gourbeyre, O., Fay, A., Palin, A., Besson-Fournier, C., Latour, C., Hopkins, C. R., Tidmarsh, G. F., Coppin, H., Roth, M. P., Ritter, M. R., Hong, C. C., & Meynard, D. (2020). U000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA. Haematologica, 105(3). https://doi.org/10.3324/HAEMATOL.2019.236133